1. Home
  2. INAB vs BRN Comparison

INAB vs BRN Comparison

Compare INAB & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • BRN
  • Stock Information
  • Founded
  • INAB 2016
  • BRN 1956
  • Country
  • INAB United States
  • BRN United States
  • Employees
  • INAB N/A
  • BRN N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • BRN Oil & Gas Production
  • Sector
  • INAB Health Care
  • BRN Energy
  • Exchange
  • INAB Nasdaq
  • BRN Nasdaq
  • Market Cap
  • INAB 14.5M
  • BRN 13.9M
  • IPO Year
  • INAB 2021
  • BRN N/A
  • Fundamental
  • Price
  • INAB $2.49
  • BRN $1.19
  • Analyst Decision
  • INAB Strong Buy
  • BRN
  • Analyst Count
  • INAB 2
  • BRN 0
  • Target Price
  • INAB $108.00
  • BRN N/A
  • AVG Volume (30 Days)
  • INAB 185.2K
  • BRN 1.4M
  • Earning Date
  • INAB 08-07-2025
  • BRN 08-12-2025
  • Dividend Yield
  • INAB N/A
  • BRN N/A
  • EPS Growth
  • INAB N/A
  • BRN N/A
  • EPS
  • INAB N/A
  • BRN N/A
  • Revenue
  • INAB N/A
  • BRN $19,387,000.00
  • Revenue This Year
  • INAB N/A
  • BRN N/A
  • Revenue Next Year
  • INAB N/A
  • BRN N/A
  • P/E Ratio
  • INAB N/A
  • BRN N/A
  • Revenue Growth
  • INAB N/A
  • BRN N/A
  • 52 Week Low
  • INAB $2.05
  • BRN $1.08
  • 52 Week High
  • INAB $27.30
  • BRN $2.53
  • Technical
  • Relative Strength Index (RSI)
  • INAB 44.14
  • BRN 44.04
  • Support Level
  • INAB $2.10
  • BRN $1.08
  • Resistance Level
  • INAB $2.30
  • BRN $1.22
  • Average True Range (ATR)
  • INAB 0.13
  • BRN 0.13
  • MACD
  • INAB 0.10
  • BRN -0.02
  • Stochastic Oscillator
  • INAB 96.70
  • BRN 11.11

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About BRN Barnwell Industries Inc.

Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.

Share on Social Networks: